Valuation (79%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 26.45 | 48.18 |
PEG Ratio (TTM) | 1.25 | 8.37 |
P/S Ratio (TTM) | 2.68 | 16.43 |
P/B Ratio (TTM) | 4.42 | 17.03 |
P/FCF Ratio (TTM) | 15.62 | 49.79 |
Price to 5YR AVG Earnings Ratio | 17.68 | 12.66 |
Price to 5YR AVG FCF Ratio | 15.52 | 56.19 |
Profitability (45%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.44% | 12.25% |
ROE (TTM) | 16.10% | 58.56% |
Net Profit Margin (TTM) | 10.20% | 24.30% |
ROIC 5YR AVG | 19.10% | -19.11% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 32.35% | 25.40% | 13.38% |
Revenue | 5.26% | 9.22% | 8.97% |
Net Income | 32.65% | 25.05% | 11.37% |
Cash Flow | 35.96% | 9.85% | 5.55% |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.97 | 1.60 |
Quick Ratio (TTM) | 1.97 | 1.59 |
D/E Ratio (TTM) | 1.90 | 0.92 |
Interest Coverage (TTM) | 1.69 | 56.25 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 2.30 | 12.19 |
LTL to 5YR AVG FCF | 6.71 | 5.14 |
Shares Outstanding Growth 5YR AVG | -2.18% | 2.47% |